BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9373448)

  • 1. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
    Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy].
    Safi S; Hassikou H; Hadri L; Sbihi A; Kadiri A
    Ann Endocrinol (Paris); 2006 Mar; 67(1):27-31. PubMed ID: 16596054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.
    Serraclara A; Jódar E; Sarabia F; Hawkins F
    J Clin Densitom; 2001; 4(3):249-55. PubMed ID: 11740067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
    Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
    Dhanwal DK; Gupta N
    J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy.
    Siderova M; Hristozov K; Tsukeva A
    Arch Endocrinol Metab; 2018; 62(2):221-226. PubMed ID: 29768627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.
    Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada M; Luna JD; Olea N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1989-94. PubMed ID: 9177418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B; Puavilai G; Rajatanavin R
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone mineral density of the femoral neck, a cross-sectional study of normal values in 827 French women aged 36 to 86 years].
    Tsouderos Y; Bauza-Canellas C; Decassin P; Denis M; Cusset B; Audrain S
    Rev Rhum Ed Fr; 1994 Jun; 61(6):439-46. PubMed ID: 7833869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
    Lucidarme N; Ruiz JC; Czernichow P; Léger J
    J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.
    Jódar Gimeno E; Muñoz-Torres M; Escobar-Jiménez F; Quesada Charneco M; Luna del Castillo JD; Oleà N
    Calcif Tissue Int; 1997 Nov; 61(5):370-6. PubMed ID: 9351877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry.
    Wakasugi M; Wakao R; Tawata M; Gan N; Inoue M; Koizumi K; Onaya T
    Thyroid; 1994; 4(2):179-82. PubMed ID: 7920000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.
    Jódar E; Martínez-Díaz-Guerra G; Azriel S; Hawkins F
    Calcif Tissue Int; 2001 Aug; 69(2):84-7. PubMed ID: 11683428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hospital based study of biochemical markers of bone turnovers & bone mineral density in north Indian women.
    Kumar A; Devi SG; Mittal S; Shukla DK; Sharma S
    Indian J Med Res; 2013 Jan; 137(1):48-56. PubMed ID: 23481051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxic bone disease in women: a potentially reversible disorder.
    Diamond T; Vine J; Smart R; Butler P
    Ann Intern Med; 1994 Jan; 120(1):8-11. PubMed ID: 8250460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis.
    Ryan PJ; Blake GM; Herd R; Parker J; Fogelman I
    Calcif Tissue Int; 1993 Apr; 52(4):263-8. PubMed ID: 8467405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of basal energy expenditure and body composition on bone mineral density in postmenopausal women.
    Quirino MA; Modesto-Filho J; de Lima Vale SH; Alves CX; Leite LD; Brandão-Neto J
    Int J Gen Med; 2012; 5():909-15. PubMed ID: 23204854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A; Holmes SJ; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density of the spine and femur in healthy Saudis.
    Ardawi MS; Maimany AA; Bahksh TM; Nasrat HA; Milaat WA; Al-Raddadi RM
    Osteoporos Int; 2005 Jan; 16(1):43-55. PubMed ID: 15167986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.